EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022

Ankit Kumar Singh, Pankaj Sonawane, Adarsh Kumar, Harshwardhan Singh, Vladislav Naumovich, Prateek Pathak, Maria Grishina iD, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid Emwas, Amita Verma iD, Pradeep Kumar iD

ACS Omega · 08.08.2023 · 8 (31) · 27819-27844

DOI: 10.1021/acsomega.3c00332 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Omega, online erschienen am 26.07.2023. Verfasst von Ankit Kumar Singh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: King Abdullah University of Science and Technology.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India.
  • Laboratory of Computational Modeling of Drugs, Higher Medical and Biological School, South Ural State University, Chelyabinsk 454008, Russia.
  • Department of Pharmaceutical Chemistry and Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Unayzah 51911, Saudi Arabia.
  • Smart-Health Initiative and Red Sea Research Center, Division of Biological and Environmental Sciences and Engineering, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia.
  • Core Laboratories, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia.
  • Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India.

ORCID-Profile: Maria Grishina, Amita Verma, Pradeep Kumar

Förderung

  • King Abdullah University of Science and Technology

Zitieren

APA

Singh, A. K., Sonawane, P., Kumar, A., Singh, H., Naumovich, V., Pathak, P., Grishina, M., Khalilullah, H., Jaremko, M., Emwas, A. H., Verma, A., & Kumar, P. (2023). Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022. ACS Omega, 8(31), 27819-27844. https://doi.org/10.1021/acsomega.3c00332

Vancouver

Singh AK, Sonawane P, Kumar A, Singh H, Naumovich V, Pathak P, et al. Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022. ACS Omega. 2023;8(31):27819-27844. doi:10.1021/acsomega.3c00332

BibTeX
@article{Singh2023,
  author = {Singh, Ankit Kumar and Sonawane, Pankaj and Kumar, Adarsh and Singh, Harshwardhan and Naumovich, Vladislav and Pathak, Prateek and Grishina, Maria and Khalilullah, Habibullah and Jaremko, Mariusz and Emwas, Abdul-Hamid and Verma, Amita and Kumar, Pradeep},
  title = {Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022},
  journal = {ACS Omega},
  year = {2023},
  volume = {8},
  number = {31},
  pages = {27819--27844},
  doi = {10.1021/acsomega.3c00332}
}
Kostenlos starten →